Objective findings3/27/2023 ![]() Increased osteoclast development after estrogen loss: mediation by interleukin-6. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. Osteoporosis: Pathophysiology and therapeutic options. 32(1):39-63.įöger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P. ![]() Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Bone quality-the material and structural basis of bone strength and fragility. Overview of osteoporosis: pathophysiology and determinants of bone strength. WHO scientific group on the assessment of osteoporosis at primary health care level: summary meeting report. Strengthening Communication on Bone Health. Clinician's Guide to Prevention and Treatment of Osteoporosis. 169(1):25-31.Ĭosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update. Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. 1117:264-72.Ĭzerwinski E, Badurski JE, Marcinowska-Suchowierska E, Osieleniec J. Selecting patients for osteoporosis therapy. A reference standard for the description of osteoporosis. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N. Evaluating bone mineral density in osteoporosis. Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. ![]() Balance characteristics of persons with osteoporosis. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |